SFU
- Product code
- SFU
- Device name
- Glucose Range Monitoring System
- Device class
- Class 2
- 21 CFR
- 21 CFR 862.1359
- Medical specialty
- Clinical Chemistry
- Marketing pathway
- 510(K)
- 510(k) clearances (last 3 years)
- 1
- Summaries archived here
- 0 (direct download)
- 510(k) clearances (all years, FDA)
- 1 (all years; only the last 3 years are listed here)
FDA classification definition
A glucose range monitoring system (GRM) is intended to automatically measure glucose in the body and provide qualitative or semi-quantitative information about glucose levels or trends continuously or frequently. GRM systems are intended to support general user awareness of glucose ranges related to glycemic control. Outputs from GRM systems do not represent quantitative glucose concentration values and GRM systems are not intended to be used for acute medical decision-making, such as insulin dosing or medication adjustment.
510(k) clearances, last 3 years (1)
| Number | Decision date | Applicant | Device name | Summary |
|---|---|---|---|---|
| DEN240080 | 2025-09-23 | Biolinq Incorporated | Biolinq Shine Autonomous Time-in-Range Microsensor | — |
Official FDA classification page: SFU
Classification and pathway per current FDA publications. Data from openFDA (CC0).